EUVIMEDEUVIMED entdecken
Crossref

Automatisation and First Evaluation of [18F]FE@SUPPY:2, an Alternative PET-Tracer for the Adenosine A3 Receptor: A Comparison with [18F]FE@SUPPY

Markus Mitterhauser, Daniela Haeusler, Leonhard-Key Mien, Johanna Ungersboeck, Lukas Nics, Rupert R Lanzenberger, Karoline Sindelar, Helmut Viernstein, Robert Dudczak, Kurt Kletter, Helmut Spreitzer, Wolfgang Wadsak

The Open Nuclear Medicine Journal · 2009

DOI: 10.2174/1876388x00901010015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Open Nuclear Medicine Journal, 2009. Verfasst von Markus Mitterhauser und 11 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Since the Adenosine-A 3 -receptor was identified in the late 1990´s, there is little data available describing its distribution in vivo.Recently, we introduced [ 18 F]FE@SUPPY as the first PET-tracer for this receptor.In the present investigation we translated this fluoroethyl-ester into the fluoroethyl-thioester [ 18 F]FE@SUPPY:2 (5-ethyl 2,4diethyl-3-((2-[ 18 F]fluoroethyl) sulfanylcarbonyl)-6-phenylpyridine-5-carboxylate).Aims of the present study were the evaluation of (1) the automatized preparation of both [ 18 F]FE@SUPPY-derivatives, (2) the biodistribution of [ 18 F]FE@SUPPY:2, (3) the lipophilicity and (4) the comparison of the findings of [ 18 F]FE@SUPPY and [ 18 F]FE@SUPPY:2. Methods:The automated preparations of both [ 18 F]FE@SUPPY-analogs were performed on a GE TRACERlab Fx FN synthesizer using suitable precursors.Biodistribution experiments were performed using Sprague-Dawley rats/Him:OFA.Lipophilicity of the compounds was determined using an HPLC assay.

Results

22 automated radiosyntheses were performed for both radiotracers.Specific radioactivity was 70 ± 26GBq/ mol for [ 18 F]FE@SUPPY and 340 ± 140GBq/ mol for [ 18 F]FE@SUPPY:2.Biodistribution experiments evinced bowels and liver as organs with highest uptake and intermediate uptake in kidney, lung and heart.LogP values of both molecules ranged from 3.99 to 4.12 at different pH.

Conclusion

From a radiopharmaceutical perspective, drastically better specific radioactivities would militate in favour of [ 18 F]FE@SUPPY:2; preclinical evaluations, so far, do not permit the decision upon the selection of the optimum [ 18 F]FE@SUPPY-derivative.With [ 18 F]FE@SUPPY:2, we are able to provide a second potential tracer that could help to further characterize the still quite unexplored Adenosine-A 3 -receptor.

Zitieren

APA

Mitterhauser, M., Haeusler, D., Mien, L., Ungersboeck, J., Nics, L., Lanzenberger, R. R., Sindelar, K., Viernstein, H., Dudczak, R., Kletter, K., Spreitzer, H., & Wadsak, W. (2009). Automatisation and First Evaluation of [18F]FE@SUPPY:2, an Alternative PET-Tracer for the Adenosine A3 Receptor: A Comparison with [18F]FE@SUPPY. The Open Nuclear Medicine Journal. https://doi.org/10.2174/1876388x00901010015

Vancouver

Mitterhauser M, Haeusler D, Mien L, Ungersboeck J, Nics L, Lanzenberger RR, et al. Automatisation and First Evaluation of [18F]FE@SUPPY:2, an Alternative PET-Tracer for the Adenosine A3 Receptor: A Comparison with [18F]FE@SUPPY. The Open Nuclear Medicine Journal. 2009. doi:10.2174/1876388x00901010015

BibTeX
@article{Mitterhauser2009,
  author = {Mitterhauser, Markus and Haeusler, Daniela and Mien, Leonhard-Key and Ungersboeck, Johanna and Nics, Lukas and Lanzenberger, Rupert R and Sindelar, Karoline and Viernstein, Helmut and Dudczak, Robert and Kletter, Kurt and Spreitzer, Helmut and Wadsak, Wolfgang},
  title = {Automatisation and First Evaluation of [18F]FE@SUPPY:2, an Alternative PET-Tracer for the Adenosine A3 Receptor: A Comparison with [18F]FE@SUPPY},
  journal = {The Open Nuclear Medicine Journal},
  year = {2009},
  doi = {10.2174/1876388x00901010015}
}
Kostenlos starten →